[8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid

C19H18F4N4O5 — CID 155863813

IUPAC[8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid
SMILESO=C(O)C(F)(F)F.O=C(c1ccnnc1)N1CC2(C1)OCCC2COc1ncccc1F
InChIInChI=1S/C17H17FN4O3.C2HF3O2/c18-14-2-1-5-19-15(14)24-9-13-4-7-25-17(13)10-22(11-17)16(23)12-3-6-20-21-8-12;3-2(4,5)1(6)7/h1-3,5-6,8,13H,4,7,9-11H2;(H,6,7)
InChIKeyKUGMNGIYXPLCMQ-UHFFFAOYSA-N
MW458.37 g/mol
LogP1.95
Rot. Bonds4

About [8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid

[8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid (PubChem CID 155863813) has the molecular formula C19H18F4N4O5 and a molecular weight of 458.37 g/mol. Its IUPAC name is [8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid.

Molecular Properties

Compound Name[8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid
PubChem CID155863813
Molecular FormulaC19H18F4N4O5
Molecular Weight458.37 g/mol
Exact Mass458.12
IUPAC Name[8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid
SMILESO=C(O)C(F)(F)F.O=C(c1ccnnc1)N1CC2(C1)OCCC2COc1ncccc1F
InChIInChI=1S/C17H17FN4O3.C2HF3O2/c18-14-2-1-5-19-15(14)24-9-13-4-7-25-17(13)10-22(11-17)16(23)12-3-6-20-21-8-12;3-2(4,5)1(6)7/h1-3,5-6,8,13H,4,7,9-11H2;(H,6,7)
InChIKeyKUGMNGIYXPLCMQ-UHFFFAOYSA-N
XLogP1.95
TPSA114.74 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds4
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500458.37
LogP ≤ 51.95
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze [8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid?
The IUPAC name of [8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid (CID 155863813) is [8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid.
What is the SMILES notation for [8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid?
The canonical SMILES for [8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid is O=C(O)C(F)(F)F.O=C(c1ccnnc1)N1CC2(C1)OCCC2COc1ncccc1F.
What is the InChIKey of [8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid?
The InChIKey is KUGMNGIYXPLCMQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H17FN4O3.C2HF3O2/c18-14-2-1-5-19-15(14)24-9-13-4-7-25-17(13)10-22(11-17)16(23)12-3-6-20-21-8-12;3-2(4,5)1(6)7/h1-3,5-6,8,13H,4,7,9-11H2;(H,6,7).
What are the key properties of [8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid?
[8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid has a molecular weight of 458.37 g/mol, XLogP of 1.95, 4 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [8-[(3-fluoro-2-pyridinyl)oxymethyl]-5-oxa-2-azaspiro[3.4]octan-2-yl]-pyridazin-4-ylmethanone;2,2,2-trifluoroacetic acid is sourced from PubChem (CID 155863813), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).